Retraction

A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients

Retraction Details

Nature of Retraction:

Retraction

Retraction Notice:
10.1177/20406223211056430
Additional Notes:

see also: https://journals.sagepub.com/doi/full/10.1177/20406223211050495;

Citations (7)

7
Total Citations
3
Post-Retraction
(42.9%)
3
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
1 After 2+ years
774 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study
Blanka Wolszczak-Biedrzycka, Justyna Dorf, Marzena Wojewódzka‐Żeleźniakowicz et al. (7 authors)
Frontiers in Immunology Open Access
Published: Jan 2024
6 citations
774 days after retraction
Biased, wrong and counterfeited evidences published during the COVID-19 pandemic, a systematic review of retracted COVID-19 papers
Angelo Capodici, Aurelia Salussolia, Francesco Sanmarchi et al. (5 authors)
Quality & Quantity Open Access
Published: Nov 2022
13 citations
373 days after retraction
Potential therapeutic options for COVID-19: an update on current evidence
Zahra Niknam, Ameneh Jafari, Ali Golchin et al. (7 authors)
European journal of medical research Open Access
Published: Jan 2022
142 citations
53 days after retraction
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad et al. (10 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Nov 2021
103 citations
9 days before retraction
Correspondence to: “A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients.”
Pankaj Bansal, Devang Sanghavi
Therapeutic Advances in Chronic Disease Open Access
Published: Jan 2021
324 days before retraction
Author response to: correspondence to: ‘A meta-analysis of granulocyte-macrophage colony-stimulating factor (GM-CSF) antibody treatment for COVID-19 patients’
Jintao Guan, Weijie Wang, Shanshan Lei et al. (4 authors)
Therapeutic Advances in Chronic Disease Open Access
Published: Jan 2021
324 days before retraction
Quick Stats
Total Citations: 12
Years Since Retraction: 4.0 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Safety and immunogenicity of a recombinant receptor-binding…
Journal of Medical Virology • 18 citations
Vaccination of multiple sclerosis patients during the COVID…
Multiple Sclerosis and Related Disorders • 0 citations
Original Antigenic Sin in COVID-19: Hoskins Effect and Vacc…
Infectious Disorders - Drug Targets • 0 citations